Emeritus Professor Ian Frazer, University of Queensland and Director of Microba, has been announced as the Millis Oration keynote speaker for AusBiotech 2023.
The title of his presentation will be ‘Navigating the future: Predictions and potential of Australian biotechnology’.
He will share his assessment of the sector’s current state and predictions for Australian biotechnology, and identify the challenges to address for Australia to develop more revolutionary health treatments while building vaccine and drug manufacturing capabilities.
His research led to the HPV vaccine Gardasil, which gained FDA approval in 2006 and is now available in more than 120 countries with more than 100 million doses having been distributed around the world.
In the wake of a global pandemic, Australia’s immediate focus is on vaccine manufacturing capacity expansion. Prof Frazer will delve into what part of this agenda the country meets currently, and what are the challenges that hinder its progress.
The Millis Oration is named in honour of Emeritus Professor Nancy Millis’ contribution to the industry, and is held annually at the national AusBiotech conference, together with CSL.
AusBiotech is Australia’s largest life science conference and will take place in Brisbane on 1-3 November.
Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World
